De Souza EB (1995) Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology 20:789 –
819.
Drolet G, Rivest S (2001) Corticotropin-releasing hormone and its
receptors: an evaluation at the transcription level in vivo. Peptides
22:761–767.
Frederic F, Chautard T, Brochard R, Chianale C, Wollman E, Oliver C,
DelhayeBouchaud N, Mariani J (1997) Enhanced endocrine re- sponse to novel environment stress and endotoxin in Lurcher mu- tant mice. Neuroendocrinology 66:341–347.
Habib KE, Weld KP, Rice KC, Pushkas J, Champoux M, Listwak S,
Webster EL, Atkinson AJ, Schulkin J, Contoreggi C, Chrousos GP,
McCann SM, Suomi SJ, Higley JD, Gold PW (2000) Oral administration of a corticotropin-releasing hormone receptor antagonist
significantly attenuates behavioral, neuroendocrine, and autonomic
responses to stress in primates. Proc Natl Acad Sci U S A 97:
6079 –6084.
Hauger RL, Millan MA, Lorang M, Harwood JP, Aguilera G (1988)
Corticotropin-releasing factor receptors and pituitary adrenal re- sponses during immobilization stress. Endocrinology 123:396 –405.
Hayley S, Brebner K, Lacosta S, Merali Z, Anisman H (1999) Sensitization to the effects of tumor necrosis factor-alpha: neuroendocrine, central monoamine, and behavioral variations. J Neurosci
19:5654 –5665.
Hayley S, Staines W, Merali Z, Anisman H (2001) Time-dependent
sensitization of corticotropin releasing hormone, arginine vasopressin and c-fos immunoreactivity within the mouse brain in response
to tumor necrosis facor-alpha. Neuroscience 106:137–148.
Hayley S, Wall P, Anisman H (2002) Sensitization to the neuroendocrine, central monoamine and behavioural effects of murine tumor
necrosis factor-alpha: peripheral and central mechanisms. Eur
J Neurosci 15:1061–1076.
Herman JP, Morrison DG (1996) Immunoautoradiographic and in situ
hybridization analysis of corticotropin-releasing hormone biosynthesis in the hypothalamic paraventricular nucleus. J Chem Neuroanat 11:49 –56.
Hernando F, Schoots O, Lolait SJ, Burbach PH (2001) Immunohistochemical localization of the vasopressin V1b receptor in the rat
brain and pituitary gland: anatomival support for its involvement in
the central effects of vasopressin. Endocrinology 142:1659 –1668.
Holmes MC, Catt KJ, Aguilera G (1987) Involvement of vasopressin in
the down-regulation of pituitary corticotropin-releasing factor receptors after adrenalectomy. Endocrinology 121:2093–2098.
Imaki T, Katsumata H, Miyata M, Naruse M, Imaki J, Minami S (2001)
Expression of corticotropin-releasing hormone type 1 receptor in
paraventricular nucleus after acute stress. Neuroendocrinology 73:
293–301.
Imaki T, Naruse M, Harada S, Chikada N, Imaki J, Onodera H, Demura
H, Vale W (1996) Corticotropin-releasing factor up-regulates its
own receptor mRNA in the paraventricular nucleus of the hypothalamus. Brain Res Mol Brain Res 38:166 –170.
Imaki T, Shibasaki T, Wang XQ, Demura H (1995) Intracerebroventricular administration of corticotropin-releasing factor antagonist
attenuates c-fos mRNA expression in the paraventricular nucleus
after stress. Neuroendocrinology 61:445–452.
Itoi K, Helmreich DL, Lopez-Figueroa MO, Watson SJ (1999) Differential regulation of corticotropin-releasing hormone and vasopressin gene transcription in the hypothalamus by norepinephrine.
J Neurosci 19:5464 –5472.
Jezova D, Ochedalski T, Kiss A, Aguilera G (1999) Central corticotropin releasing hormone receptors modulate hypothalamic pituitary adrenocortical and sympathoadrenal activity during stress.
Neuroscience 94:797–802.
Kalsbeek A, Van Heerikhuize JJ, Wortel J, Buijs RM (1996) A diurnal
rhythm of stimulatory input to the hypothalamo-pituitary-adrenal
system as revealed by timed intrahypothalamic administrator of the
vasopressin V1 antagonist. J Neurosci 16:5555–5565.
